血清sCD40L和sTREM-1联合危重症评分对严重脓毒症住院患者预后的预测价值OA
Predictive value of serum soluble CD40 ligand and soluble triggering receptor expressed on myeloid cells-1 combined with critical care severity scores for in-hospital mortality in patients with severe sepsis
目的 评估可溶性 CD40 配体(sCD40L)、可溶性髓系细胞触发受体 1(sTREM-1)联合急性生理学与慢性健康状况评分Ⅱ(APACHEⅡ)及序贯器官衰竭评分(SOFA)在预测严重脓毒症患者院内死亡中的临床效能.方法 选择 2024 年 8 月至 2025 年 7 月济宁医学院附属医院重症监护病房(ICU)收治的 203 例严重脓毒症患者作为研究对象.根据住院期间生存结局将患者分为生存组与死亡组.系统收集患者人口学资料、入住 ICU 即刻生命体征、疾病严重程度评分、入院 24 h 内实验室指标、ICU 住院时间、住院转归,以及脓毒症确诊后 2 h内的sCD40L、sTREM-1 水平,比较不同预后两组间上述指标的差异.采用多因素Logistic 回归分析sCD40L、sTREM-1 联合 APACHEⅡ与 SOFA 评分对患者预后的影响,并绘制受试者工作特征曲线(ROC 曲线)评价各指标及联合模型对严重脓毒症患者预后的预测效能.结果 203 例患者中存活 178 例、死亡 25 例,住院病死率12.32%.死亡组sCD40L、sTREM-1、APACHEⅡ评分及SOFA评分均明显高于生存组[sCD40L(μg/L):4.8(2.5,6.7)比 1.1(0.4,4.1),sTREM-1(ng/L):1 781.7(1 338.7,1 942.7)比 944.5(495.4,1 453.2),APACHEⅡ评分(分):26.7±7.3 比 21.6±7.6,SOFA 评分(分):11(8,14)比 7(5,10),均 P<0.05].多因素 Logistic 回归分析显示,sCD40L、sTREM-1、APACHE Ⅱ及 SOFA 评分均为影响脓毒症住院患者死亡的独立危险因素(均 P<0.05),校正混杂因素后结果稳健.ROC 曲线分析表明,sCD40L+sTREM-1+SOFA 评分联合模型的 ROC曲线下面积(AUC)为 0.838 2[95%可信区间(95%CI)为 0.775 1~0.901 3],P=0.000 0,预测效能优于sCD40L+sTREM-1+APACHEⅡ评分、sCD40L+sTREM-1 及各单项指标 sCD40L、sTREM-1、APACHEⅡ评分和SOFA评分[AUC(95%CI)分别为 0.802 5(0.718 2~0.886 7)、0.784 3(0.700 4~0.868 2)、0.758 2(0.666 9~0.849 5)、0.755 7(0.662 7~0.848 7)、0.701 9(0.599 8~0.803 9)、0.745 1(0.660 6~0.829 5)].结论 sCD40L、sTREM-1联合SOFA评分对脓毒症住院患者预后有较好的预测价值,且效能优于任一单一指标.
Objective To evaluate the clinical value of soluble CD40 ligand(sCD40L)combined with soluble triggering receptor expressed on myeloid cells-1(sTREM-1),together with the acute physiology and chronic health evaluation Ⅱ(APACHEⅡ)score and the sequential organ failure assessment(SOFA)score,in predicting in-hospital mortality of patients with severe sepsis.Methods A total of 203 patients with severe sepsis admitted to the department of intensive care unit(ICU)of the Affiliated Hospital of Jining Medical University from August 2024 to July 2025 were enrolled.Patients were divided into survival and death groups according to their in-hospital outcomes.Demographic data vital signs on ICU admission,disease severity scores,laboratory indicators within 24 hours of admission,ICU length of stay,hospital outcomes,sCD40L and sTREM-1 levels within 2 hours after sepsis diagnosis were systematically collected.Differences in these parameters were detected between the two groups.Multivariable Logistic regression analysis was used to analyze the effects of sCD40L,sTREM-1 combined with APACHEⅡand SOFA scores on in-hospital mortality.Receiver operator characteristic curve(ROC curve)were used to evaluate the predictive performance of individual indicators and combined models for the prognosis of patients with severe sepsis.Results Of the 203 patients,178 survived and 25 died,yielding an in-hospital mortality of 12.32%.sCD40L,sTREM-1,APACHEⅡscore,and SOFA score were significantly higher in the death group than in the survival group[sCD40L(μg/L):4.8(2.5,6.7)vs.1.1(0.4,4.1),sTREM-1(ng/L):1 781.7(1 338.7,1 942.7)vs.944.5(495.4,1 453.2),APACHEⅡ score:26.7±7.3 vs.21.6±7.6,SOFA score:11(8,14)vs.7(5,10);all P<0.05].Multivariable Logistic regression showed that sCD40L,sTREM-1,APACHE Ⅱ,and SOFA scores were independent risk factors for in-hospital mortality(all P<0.05),and the results remained robust after adjustment for confounders.ROC curve analysis showed that the combined sCD40L+sTREM-1+SOFA model yielded an area under the curve(AUC)of 0.838 2[95%confidence interval(95%CI):0.775 1-0.901 3],P=0.000 0,demonstrating superior predictive performance compared with sCD40L+sTREM-1+APACHEⅡ,sCD40L+sTREM-1,and each individual indicator sCD40L,sTREM-1,APACHE Ⅱ score,and SOFA score[AUC(95%CI):0.802 5(0.718 2-0.886 7),0.784 3(0.700 4-0.868 2),0.758 2(0.666 9-0.849 5),0.755 7(0.662 7-0.848 7),0.701 9(0.599 8-0.803 9),and 0.745 1(0.660 6-0.829 5),respectively].Conclusion sCD40L combined with sTREM-1 and SOFA score has good predictive value for in-hospital mortality in patients with sepsis,outperforming any single indicator.
毕春华;吴冬梅;郝翠平;倪宸;朱曼晨;亓志玲;张宗峰;李宗强;李媛青;刘安昊;胡庆河
济宁医学院护理学院,山东 济宁 272067济宁医学院护理学院,山东 济宁 272067济宁医学院附属医院重症医学科,山东 济宁 272030济宁医学院临床学院,山东 济宁 272067济宁医学院附属医院重症医学科,山东 济宁 272030济宁医学院附属医院重症医学科,山东 济宁 272030济宁医学院附属医院重症医学科,山东 济宁 272030济宁医学院附属医院重症医学科,山东 济宁 272030山东第一医科大学护理学院,山东 泰安 271000山东第一医科大学护理学院,山东 泰安 271000济宁医学院附属医院重症医学科,山东 济宁 272030
可溶性CD40配体可溶性髓系细胞触发受体1急性生理学与慢性健康状况评分Ⅱ序贯器官衰竭评分脓毒症预后预测价值
Soluble CD40 ligandSoluble triggering receptor expressed on myeloid cells-1Acute physiology and chronic health evaluationⅡSequential organ failure assessmentSepsisPrognosisPredictive value
《中国中西医结合急救杂志》 2026 (4)
403-407,5
吴阶平医学基金会科研专项资助基金(320.6750.2024-07-4) Wu Jieping Medical Foundation Research Special Grant Fund(320.6750.2024-07-4)
评论